Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Contents
Current Neuropharmacology, Volume 16 - Number 6
Biography Open Access
Meet Our Editorial Board Member
, 16(6): 645 - 646Maurizio Popoli
DOI: 10.2174/1570159X1606180608103453
Editorial Open Access
Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases
, 16(6): 647 - 648Luciana Scotti and Marcus T. Scotti
DOI: 10.2174/1570159X1606180608103840
Review Article
Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design
, 16(6): 649 - 663Sheikh Arslan Sehgal*, Mirza A. Hammad, Rana Adnan Tahir, Hafiza Nisha Akram and Faheem Ahmad
DOI: 10.2174/1570159X16666180315142137
Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design
Review Article
In Silico Studies in Drug Research Against Neurodegenerative Diseases
, 16(6): 664 - 725Farahnaz Rezaei Makhouri and Jahan B. Ghasemi*
DOI: 10.2174/1570159X15666170823095628
In Silico Studies in Drug Research Against Neurodegenerative Diseases
Review Article
Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design
, 16(6): 726 - 739Akhil Kumar*, Ashish Tiwari and Ashok Sharma*
DOI: 10.2174/1570159X16666180315141643
Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design
Review Article
Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders
, 16(6): 740 - 748Mohammad Hassan Baig*, Khurshid Ahmad, Gulam Rabbani, Mohd Danishuddin and Inho Choi*
DOI: 10.2174/1570159X15666171016163510
Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders
Review Article
QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
, 16(6): 749 - 757Michelle Fidelis Correa* and Joao Paulo dos Santos Fernandes*
DOI: 10.2174/1570159X15666170818100644
QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
Review Article
Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease
, 16(6): 758 - 768Hui Li, Xiaobing Wang, Hongmei Yu, Jing Zhu, Hongtao Jin, Aiping Wang and Zhaogang Yang*
DOI: 10.2174/1570159X15666171030142108
Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease
Review Article
Blood Brain Barrier and Alzheimer’s Disease: Similarity and Dissimilarity of Molecular Alerts
, 16(6): 769 - 785Alla P. Toropova*, Andrey A. Toropov, Sanija Begum and Patnala G.R. Achary
DOI: 10.2174/1570159X15666171016163951
Blood Brain Barrier and Alzheimer’s Disease: Similarity and Dissimilarity of Molecular Alerts
Review Article
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
, 16(6): 786 - 848Agostinho Lemos, Rita Melo, Antonio Jose Preto, Jose Guilherme Almeida, Irina Sousa Moreira* and Maria Natalia Dias Soeiro Cordeiro*
DOI: 10.2174/1570159X16666180308161642
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
Review Article
Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge?
, 16(6): 849 - 864Riccardo Zanni, Ramon Garcia-Domenech, Maria Galvez-Llompart and Jorge Galvez*
DOI: 10.2174/1570159X15666171129102042
Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge?
Review Article
Computer-aided Drug Design Applied to Parkinson Targets
, 16(6): 865 - 880Hamilton M. Ishiki, Jose Maria Barbosa Filho, Marcelo S. da Silva, Marcus T. Scotti and Luciana Scotti*
DOI: 10.2174/1570159X15666171128145423
Computer-aided Drug Design Applied to Parkinson Targets
Review Article
3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors
, 16(6): 881 - 900Priyanka Dhiman, Neelam Malik and Anurag Khatkar*
DOI: 10.2174/1570159X15666171128143650
3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors
Editor-in-Chief
Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
(Italy)
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net